FMB Wealth Management’s AnaptysBio ANAB Stock Holding History

FMB Wealth Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$377K	Hold	5,592	–	–	0.14%	59
2026 Q1	$310K	Hold	5,592	–	–	0.13%	61
2025 Q4	$271K	Buy	+5,592	New	+$218K	0.11%	73
2025 Q3	–	Sell	-35,592	Closed	-$790K	–	90
2025 Q2	$790K	Hold	35,592	–	–	0.38%	41
2025 Q1	$662K	Hold	35,592	–	–	0.37%	40
2024 Q4	$471K	Hold	35,592	–	–	0.27%	49
2024 Q3	$1.19M	Hold	35,592	–	–	0.67%	29
2024 Q2	$892K	Hold	35,592	–	–	0.68%	28
2024 Q1	$802K	Hold	35,592	–	–	0.64%	30
2023 Q4	$762K	Hold	35,592	–	–	0.7%	28
2023 Q3	$639K	Hold	35,592	–	–	0.69%	28
2023 Q2	$724K	Hold	35,592	–	–	0.77%	26
2023 Q1	$774K	Sell	35,592 -3,667	-9%	-$89.1K	0.92%	25
2022 Q4	$1.22M	Buy	+39,259	New	+$1.11M	1.57%	18

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

FMB Wealth Management's ANAB Position: Q2 2026 in Review

FMB Wealth Management held its AnaptysBio (ANAB) position steady in Q2 2026 at 5,592 shares worth $377K. The position accounts for 0.14% of the portfolio, ranked #59.

FMB Wealth Management first reported a position in ANAB in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.22M in Q4 2022. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

FMB Wealth Management held 5,592 shares of AnaptysBio worth $377K as of Q2 2026.
FMB Wealth Management left its AnaptysBio share count unchanged in Q2 2026.
AnaptysBio made up 0.14% of FMB Wealth Management's portfolio in Q2 2026, its #59 holding.
FMB Wealth Management first reported a position in AnaptysBio in Q4 2022 and has held it in 14 quarters since.
FMB Wealth Management's AnaptysBio position peaked at $1.22M in Q4 2022.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on FMB Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.